3 terminated, 1 completed, 1 unknown. 5 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Terminated 3, Completed 1, Unknown 1 |
| Phase 2 | 3 | Completed 1, Terminated 1, Unknown 1 |
Follow Immunologic Factors: new trials by email Literature Review of Immunologic Factors trials Research Report on Immunologic Factors
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of the Immunogenicity, Safety and Tolerability of the Convacell Vaccine. Subunit recombinant vaccine for the prevention of coronavirus infection, Placebo - COVID-19, Immunologic Factors | Phase 1 / Phase 2 | Completed | St. Petersburg Research Institute of Vaccines and Sera | 155 | 2021-07-19 | 2023-08-30 |
| Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients. Dendritic Cell/Tumor Fusion Vaccine, Interleukin-12, Temozolomide - Glioblastoma, Glioma | Phase 1 / Phase 2 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 10 | 2020-12-01 | 2020-06-09 |
| Natural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBM CYNK001-IV, CYNK001-IT - Astrocytoma, Grade IV, Giant Cell Glioblastoma | Phase 1 | Terminated | Celularity Incorporated | 3 | 2020-10-01 | 2022-08-10 |
| Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19 CYNK-001 - Coronavirus, Coronavirus Infection | Phase 1 / Phase 2 | Terminated | Celularity Incorporated | 7 | 2020-09-02 | 2026-06-26 |
| Natural Killer Cell (CYNK-001) Infusions in Adults with AML CYNK-001 - Leukemia, Leukemia, Myeloid | Phase 1 | Terminated | Celularity Incorporated | 27 | 2020-03-12 | 2024-12-12 |
COVID-19 (2) · Coronavirus Infections (2) · Glioblastoma (2) · Neoplasms (2) · Respiratory Tract Infections (2) · Coronaviridae Infections (1) · Glioma (1) · Hematologic Diseases (1) · Hematologic Neoplasms (1) · Immune System Diseases (1) · Leukemia (1) · Leukemia, Myeloid (1) · Leukemia, Myeloid, Acute (1) · Lung Diseases (1) · Neoplasm, Residual (1)
Astrocytoma (2) · Infections (2) · Neoplasms by Histologic Type (2) · Neoplasms, Germ Cell and Embryonal (2) · Neoplasms, Glandular and Epithelial (2) · Coronaviridae Infections (1) · Glioma (1) · Hemic and Lymphatic Diseases (1) · Lung Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Neoplasms, Nerve Tissue (1) · Neoplasms, Neuroepithelial (1) · Neoplastic Processes (1) · Neuroectodermal Tumors (1)
Interleukin-12 (1) · Temozolomide (1)
Celularity Incorporated (3) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1) · St. Petersburg Research Institute of Vaccines and Sera (1)
United States (3) · China (1) · Russia (1)
Corey Casper, MD MPH (1) · Hong Shen, MD (1) · Sharmila Koppisetti, M.D (1) · Sharmila Koppisetti, MD (1)